CO4910165A1 - Procedimiento para elaboracion de derivados de 2-amino-2- imidazolina, guanidina y 2-amino-3,4,5,6-tetrahidropirimidi- na - Google Patents

Procedimiento para elaboracion de derivados de 2-amino-2- imidazolina, guanidina y 2-amino-3,4,5,6-tetrahidropirimidi- na

Info

Publication number
CO4910165A1
CO4910165A1 CO97068899A CO97068899A CO4910165A1 CO 4910165 A1 CO4910165 A1 CO 4910165A1 CO 97068899 A CO97068899 A CO 97068899A CO 97068899 A CO97068899 A CO 97068899A CO 4910165 A1 CO4910165 A1 CO 4910165A1
Authority
CO
Colombia
Prior art keywords
methylene group
amino
membered ring
group connected
ethyl
Prior art date
Application number
CO97068899A
Other languages
English (en)
Inventor
Michael Godlewski
Reddy Mundla Screenivasa
William Lee Seibel
Sean Rees Klopfenstein
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of CO4910165A1 publication Critical patent/CO4910165A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44Nitrogen atoms not forming part of a nitro radical
    • C07D233/50Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La presente invención se relaciona con un método paraelaborar derivados 2-amino-2-imidazolina, guanidina o 2-amino-3,4,5,6-tetrahidropirimidina que tiene la estructura general: o los tautómeros de ellos, donde: (a) R1 es metilo, etilo, un grupo metileno conectado a R2 a través de un enlace sencillo de forma que R1 y R2 formen un anillo de cinco miembros o un grupo metileno conectado a R" a través de otro grupo metileno forma que R1 y R2 formen un anillo de seis miembros; (b) R2 es metilo, etilo, un grupo metileno conectado a R1 a través de un enlace sencillo de forma que R1 y R2 formen un anillo de cinco miembros o un grupo metileno conectado a R1 a través de otro grupo metileno de forma que R1 y R2 formen un anillo de seis miembros; (c) Z es un carbociclo o heterociclo saturado, no saturado o aromático, monocíclico o policíclico que contiene uno o más heteroátomos seleccionados de O, N ó S; y (d) R4 es uno o más sustituyentes en el anillo Z que contiene independientemente hidrógeno, alcoxi, alquiltio alquilo, alquenilo, amino, ciano, halógeno, hidroxi, nitro y tiol; (e) o una forma protegida, sal, sal farmacéuticamente aceptable, éster biohidrolizable o solvato de ellos;el cual comprende los pasos de: (I) preparar un intermedio que tenga la estructura general: donde (a) R es seleccionado del grupo consistente de metilo, etilo y benzilo; (b) R1 es metilo, etilo, un grupo metileno conectado a R2 a través de un enlace sencillo de forma que R1 y R2 formen un anillo de cinco miembros o un grupo metileno conectado a R" a través de otro grupo metileno de forma que R1 y R2 formen un anillo de seis miembros;...
CO97068899A 1996-11-25 1997-11-25 Procedimiento para elaboracion de derivados de 2-amino-2- imidazolina, guanidina y 2-amino-3,4,5,6-tetrahidropirimidi- na CO4910165A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3431896P 1996-11-25 1996-11-25

Publications (1)

Publication Number Publication Date
CO4910165A1 true CO4910165A1 (es) 2000-04-24

Family

ID=21875679

Family Applications (1)

Application Number Title Priority Date Filing Date
CO97068899A CO4910165A1 (es) 1996-11-25 1997-11-25 Procedimiento para elaboracion de derivados de 2-amino-2- imidazolina, guanidina y 2-amino-3,4,5,6-tetrahidropirimidi- na

Country Status (21)

Country Link
EP (1) EP0944603B1 (es)
JP (1) JP2001506605A (es)
KR (1) KR20000069132A (es)
AR (1) AR008920A1 (es)
AT (1) ATE232851T1 (es)
AU (1) AU732056B2 (es)
BR (1) BR9713296A (es)
CA (1) CA2272690C (es)
CO (1) CO4910165A1 (es)
CZ (1) CZ183599A3 (es)
DE (1) DE69719210T2 (es)
DK (1) DK0944603T3 (es)
ID (1) ID22896A (es)
IL (1) IL130095A0 (es)
NO (1) NO312721B1 (es)
PE (1) PE28099A1 (es)
SK (1) SK69899A3 (es)
TR (1) TR199901484T2 (es)
TW (1) TW472043B (es)
WO (1) WO1998023595A1 (es)
ZA (1) ZA9710581B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0775134A4 (en) 1994-08-04 1997-08-13 Synaptic Pharma Corp NEW BENZIMIDAZOLE DERIVATIVES
US6495583B1 (en) 1997-03-25 2002-12-17 Synaptic Pharmaceutical Corporation Benzimidazole derivatives
US20040167194A1 (en) 2003-02-20 2004-08-26 Randall Jared Lynn Methods of making 6-[(4,5-Dihydro-1H-imidazol-2-yl)amino-]-7-methyl-1H-benzimidazole-4-carbonitrile and its preferred salt form
US11077053B2 (en) 2018-08-21 2021-08-03 Allergan, Inc. Alpha-2-adrenergic receptor agonists for treatment of presbyopia, visual glare, visual starbursts, visual halos and night myopia

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670807A1 (de) * 1967-02-17 1971-03-11 Bayer Ag Verfahren zur Herstellung von cyclischen Guanidinen
DE2854659A1 (de) * 1978-12-18 1980-07-10 Boehringer Sohn Ingelheim Neue 3,4-disubstituierte 2-phenylimino-imidazolidine, deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zu deren herstellung

Also Published As

Publication number Publication date
DE69719210D1 (de) 2003-03-27
SK69899A3 (en) 2000-01-18
NO992501L (no) 1999-07-22
ATE232851T1 (de) 2003-03-15
NO992501D0 (no) 1999-05-25
TR199901484T2 (xx) 1999-09-21
EP0944603B1 (en) 2003-02-19
BR9713296A (pt) 1999-10-26
NO312721B1 (no) 2002-06-24
CA2272690C (en) 2004-07-13
WO1998023595A1 (en) 1998-06-04
AU732056B2 (en) 2001-04-12
DE69719210T2 (de) 2004-02-12
AR008920A1 (es) 2000-02-23
ZA9710581B (en) 1998-06-12
IL130095A0 (en) 2000-02-29
TW472043B (en) 2002-01-11
PE28099A1 (es) 1999-03-31
JP2001506605A (ja) 2001-05-22
CZ183599A3 (cs) 1999-10-13
EP0944603A1 (en) 1999-09-29
KR20000069132A (ko) 2000-11-25
ID22896A (id) 1999-12-16
CA2272690A1 (en) 1998-06-04
DK0944603T3 (da) 2003-06-16
AU7402198A (en) 1998-06-22

Similar Documents

Publication Publication Date Title
ES2189330T3 (es) Derivados heterociclicos n6 de la adenosina sustituidos.
CO4930282A1 (es) Cicloalquilo lactama lactona y compuestos relacionados composiciones farmaceuticas que comprenden los mismos metodos para inhibir la liberacion del peptido -amiloide y/o su sintesis mediante el uso de dichos compuestos
ES2185338T3 (es) Derivados de fumagilol y procedimientos para su fabricacion.
UY25987A1 (es) Procedimiento para preparar complejo del inhibidor de ras-fa rnesiltransferasa y sulfobutileter-7-beta-ciclodextrina o 2- hidroxipropil-beta-ciclodextrina y método
CO5080778A1 (es) Inhibidores de enzimas
CO5590894A2 (es) Derivados de a-(n-sulfonamido)acetamida como inhibidores del peptido b-amiloideo
AR038762A1 (es) Derivados de indolina, un proceso para su preparacion, composicion farmaceutica, proceso para la preparacion de dicha composicion y el uso de dichos derivados para la fabricacion de un medicamento
RU2291860C3 (ru) Производные 2-оксо-1-пирролидина, способ их получения и применения
CO5640080A2 (es) Compuestos que modulan la actividad ppar y procedimiento para su preparacion
CO5080767A1 (es) Derivados sulfonamida
ES2193730T3 (es) Ligandos de receptores de la hormona tiroidea y de glucocortioides para el tratamiento de desordenes metabolicos.
AR053301A1 (es) Derivados de pirazina y su uso farmaceutico
ES2162668T3 (es) Derivados de bifenilo o de fenil-piridina sustituidos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
EA200600348A1 (ru) Новые соединения
DK0628311T3 (da) Xanthinderivater som antidepressive midler
DE60041763D1 (de) Inhibitoren von c-jun n-terminal kinasen (jnk)
ECSP082712A (es) Procedimiento i para preparar derivados de tiazolidindiona
CY1108002T1 (el) Παραγωγα 4-ετεροκυκλυλοσουλφοναμιδυλο-6-μεθοξυ-5- (2-μεθοξυ-φαινοξυ)-2-πυριδυλο-πυριμιδινης, παρασκευη αυτων, και χρηση τους ως ανταγωνιστες υποδοχεα ενδοθηλινης
AR010080A1 (es) Derivados de 1,2,3,4-tetrahidronaftaleno
ECSP034531A (es) Derivados sustituidos de c-ciclohexilmetilamina
AR035110A1 (es) Compuesto derivado de piperazina, uso del mismo para la preparacion de una composicion farmaceutica, composicion farmaceutica que lo comprende y procedimiento para la preparacion de dicho compuesto
MX9306310A (es) Compuestos antagonistas del receptor de 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
CO4910165A1 (es) Procedimiento para elaboracion de derivados de 2-amino-2- imidazolina, guanidina y 2-amino-3,4,5,6-tetrahidropirimidi- na
KR960037677A (ko) 4-인돌릴피페라지닐 유도체
AR027644A1 (es) Compuestos de piridacinil fenil hidrazona, composicion farmaceutica que lo comprende y metodo para el tratamiento de una falla del corazon congestiva quelo emplea